Vimarsana
Biggest News Aggregation in the World

Structure Therapeutics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Structure Therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Structure Therapeutics Today - Breaking & Trending Today

Gilead Stock Jumps After Its Weight-Loss Drug Emerges From Under The Radar - Vimarsana News

Gilead Stock Jumps After Its Weight-Loss Drug Emerges From Under The Radar

Gilead stock jumped Friday after surprising Wall Street with preclinical test results for an under-the-radar weight-loss drug.

Avoro Capital Advisors LLC Grows Stake in Structure Therapeutics Inc. (NASDAQ:GPCR) - Vimarsana News

Avoro Capital Advisors LLC Grows Stake in Structure Therapeutics Inc. (NASDAQ:GPCR)

Avoro Capital Advisors LLC raised its position in shares of Structure Therapeutics Inc. (NASDAQ:GPCR – Free Report) by 133.3% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,333,333 shares of the company’s stock after buying an additional 1,333,333 shares during the […]

Structure Therapeutics Announces Closing of Upsized Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional American Depositary Shares - Structure Therapeutics (NASDAQ:GPCR) - Vimarsana News

Structure Therapeutics Announces Closing of Upsized Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional American Depositary Shares - Structure Therapeutics (NASDAQ:GPCR)

SAN FRANCISCO, June 07, 2024 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ:GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic and

Structure Therapeutics Announces Pricing of Upsized $476 Million Public Offering - Vimarsana News

Structure Therapeutics Announces Pricing of Upsized $476 Million Public Offering

SAN FRANCISCO, June 05, 2024 -- Structure Therapeutics Inc. , a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic and cardiopulmonary...

Qiming's Nisa Leung Made the 2024 Forbes Midas List - Vimarsana News

Qiming's Nisa Leung Made the 2024 Forbes Midas List

SHANGHAI, June 4, 2024 /PRNewswire/ -- The 2024 Forbes Midas List, a distinguished industry list of the world's best venture capital investors, has been unveiled. Nisa Leung, Managing Partner at